StonvexLoading…
StonvexStonvexStonvexCore line items from CANG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2022 2022-12-31 | Annual 2021 2021-12-31 |
|---|---|---|---|---|
Revenue | $688.08M | $89.91M | $287.14M | $615.40M |
Operating Income | $-437.10M | $-5.11M | $-137.32M | $-3.65M |
Net Income | $-621.95M | $41.65M | $-161.11M | $-1.34M |
EPS (Diluted) | $-1.60 | $0.02 | Not available | Not available |
Total Assets | $1.13B | $817.78M | $1.02B | $1.72B |
Total Liabilities | $735.94M | $263.91M | $390.64M | $620.87M |
Cash & Equivalents | $41.24M | $90.43M | $54.94M | $225.15M |
Free Cash Flow OCF − CapEx | $-119.24M | $-40.90M | $-82.93M | $-66.43M |
Shares Outstanding | 283.29M | 233.03M | 274.08M | 289.89M |